By Kashmira Konduparty
The White House announced a major expansion of the government-backed prescription drug platform TrumpRx, adding more than 600 generic medications.
The platform will now connect users to discounted generic drugs through companies including Amazon Pharmacy, GoodRx and Mark Cuban Cost Plus Drugs, according to State News. The move is part of the administration’s broader push to lower prescription drug prices for Americans paying out of pocket.
TrumpRx is a government-supported online prescription drug marketplace launched earlier this year. The platform does not directly sell medications but instead redirects users to discounted purchasing options from participating companies. The platform was initially focused on brand name drugs before expanding into generics.
READ: What is TrumpRx? Trump launches new website offering lower drug prices (February 6, 2026)
The expansion adds more than 600 generic drugs including widely used medications such as atorvastatin, metformin and blood pressure treatments. Generics account for more than 90% of prescriptions filled in the United States. Officials said the broader catalog is intended to increase affordability and access for uninsured or cash-paying customers.
Billionaire entrepreneur Mark Cuban appeared alongside President Donald Trump during the announcement. Cuban’s Cost Plus Drugs platform joined the initiative along with Amazon Pharmacy and GoodRx. Cuban said reducing prescription drug costs should be treated as a bipartisan issue rather than a political one.
Healthcare analysts and critics questioned whether TrumpRx truly offers the lowest prices available. Earlier reporting from Stat found that many drugs listed on platform already had cheaper generic alternatives available elsewhere. Experts also noted that purchases made through TrumpRx may not count toward insurance deductibles or out-of-pocket maximums.
READ: The Great Healthcare Plan: Why talking about seeing is not the same as prescribing glasses (January 16, 2026)
Prescription drug affordability remains one of the most debated healthcare issues in the United States. Both Republicans and Democrats have proposed different approaches to lowering costs, including Medicare price negotiations, caps on insulin prices and reforms targeting pharmacy benefit managers. TrumpRx has become part of the broader political debate over government involvement in healthcare pricing.
The platform is primarily aimed at people without strong insurance coverage or those paying cash for prescriptions. Officials said users will be able to compare prices, locate nearby pharmacies and arrange home delivery through partner services. Supporters say the expansion could improve price transparency in the pharmaceutical market.
The expansion of TrumpRx reflects growing pressure on both government officials and private companies to address rising healthcare costs in the United States. As debates over prescription drug pricing continue, partnerships between government programs and private-sector pharmacy platforms are likely to play an increasingly visible role in the healthcare industry.